NCT04609111View on ClinicalTrials.gov

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

6,002

Participants

Timeline

Start Date

January 29, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Acute Coronary Syndrome
Interventions
DRUG

No aspirin

1-month prasugrel monotherapy followed by clopidogrel monotherapy

DRUG

1-month DAPT

1-month dual antiplatelet therapy comprising of aspirin and prasugrel followed by aspirin monotherapy

Trial Locations (1)

606-8507

Kyoto University Graduate School of Medicine, Kyoto

All Listed Sponsors
lead

Kyoto University, Graduate School of Medicine

OTHER